Sensitizing HR-proficient cancers to PARP inhibitors.

Lim, Elgene; Johnson, Shawn F; Geyer, Matthias; Serra, Violeta; Shapiro, Geoffrey I.

Affiliation

Lim E; Garvan Institute of Medical Research and St. Vincent's Health Network, Darlinghurst, NSW, Australia.
Johnson SF; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Geyer M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Serra V; Department of Structural Immunology, Institute of Innate Immunity, University of Bonn, Bonn, Germany.
Shapiro GI; Group Physical Biochemistry, Center of Advanced European Studies and Research, Bonn, Germany.

Mol Cell Oncol ; 4(6): e1299272, 2017.

Article in En | MEDLINE | ID: mdl-29209638